FDA OKs expanded use of Roche cervical cancer test

The FDA approves expanded use of Roche’s (OTCQX:RHHBY) CINtec PLUS Cytology test to be used as triage for positive cobas HPV tests performed on the automated cobas 6800 and 8800 systems in primary screening or co-testing programs.

The company says CINtec PLUS is more sensitive than a PAP smear and allows physicians to determine which HPV-positive women require further diagnostic procedures to prevent disease progression.

https://seekingalpha.com/news/3614454-fda-oks-expanded-use-of-roche-cervical-cancer-test